Group One Trading
INBX icon

Group One Trading’s Inhibrx INBX Stock Holding History

Group One Trading’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$33.6K Sell
500
-88,900
-99% -$6.59M ﹤0.01% 5566
2025
Q4 		$7.06M Buy
+89,400
New +$6.09M 0.01% 1209
2025
Q2 		– Sell
-15,300
Closed -$214K – 8251
2025
Q1 		$214K Buy
15,300
+14,900
+3,725% +$202K ﹤0.01% 3956
2024
Q4 		$6.16K Sell
400
-400
-50% -$6.09K ﹤0.01% 6323
2024
Q3 		$12.5K Sell
800
-300
-27% -$4.21K ﹤0.01% 5495
2024
Q2 		$15.6K Buy
+1,100
New +$17.2K ﹤0.01% 5385

Other funds holding INBX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Group One Trading's INBX Position: Q1 2026 in Review

Group One Trading reduced its Inhibrx (INBX) stake by 10% in Q1 2026, selling an estimated $41.2K and leaving 4,803 shares worth $323K. The position accounts for ﹤0.01% of the portfolio, ranked #3735.

Group One Trading first reported a position in INBX in Q2 2024 and has held it in 6 quarters since. The position peaked at $423K in Q4 2025. 135 funds tracked by Wall St. Rank hold INBX as of Q1 2026.

  • Group One Trading held 4,803 shares of Inhibrx worth $323K as of Q1 2026.
  • Group One Trading sold 555 Inhibrx shares in Q1 2026, an estimated $41.2K.
  • Inhibrx made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #3735 holding.
  • Group One Trading first reported a position in Inhibrx in Q2 2024 and has held it in 6 quarters since.
  • Group One Trading's Inhibrx position peaked at $423K in Q4 2025.
  • 135 funds tracked by Wall St. Rank held Inhibrx as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.